ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2859

Pain Pathway Activation In Dorsal Root Ganglia and Dorsal Horn In a Murine Surgical Model Of Osteoarthritis

Rachel E. Miller1, Phuong Tran2, Richard J. Miller3 and Anne-Marie Malfait4, 1Rheumatology/Biochemistry, Rush University Medical Center, Chicago, IL, 2Rheumatology, Rush University Medical Center, Chicago, IL, 3Molecular Biochemistry and Pharmacology, Northwestern University, Chicago, IL, 4Internal Medicine/Biochemistry, Rush University Medical Center, Chicago, IL

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Mouse model, osteoarthritis and pain

  • Tweet
  • Email
  • Print
Session Information

Title: Orthopedics, Low Back Pain, Rehabilitation and Mechanisms of Pain in Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Using a surgical mouse model of osteoarthritis (OA), destabilization of the medial meniscus (DMM), we monitor pain and associated pathways over a period of 16 weeks post surgery.  We observed longitudinal changes in pain-related behaviors as joint disease progresses, with concomitant molecular changes in the innervating DRG (Miller et al, 2012, PNAS).  Specifically, mice develop progressive mechanical allodynia in the ipsilateral hindpaw over the first 4 weeks, while locomotive changes indicative of chronic pain appear 8 weeks after DMM.  It has been hypothesized that activation of microglia in the dorsal horn (DH) – a dynamic process that contributes to pain through further neuronal activation – is dependent on signaling molecules (ie MCP-1 and fractalkine (CX3CL1)) that originate in DRG neurons and are transported to the DH, where they can act on microglia (Miller et al, 2009, Handb Exp Pharmacol). Our previous work has focused on MCP-1/CCR2 signaling in DRG neurons after DMM surgery. Here, we examined fractalkine expression in the DRG and activation of microglia and neurons in the DH following DMM surgery.

Methods:

Animal procedures were approved by Rush University Medical Center.  DMM or sham surgery was performed in the right knee of 10-week old male wild-type C57BL/6 mice.  Pain-dependent behaviors were assessed at 0, 4, 8, and 16 weeks post surgery.  Mechanical allodynia in the hind paw was assessed with von Frey fibers.  Locomotion was assessed using a LABORAS platform, as described (Miller et al, 2012, PNAS).  Eight weeks post DMM, L3-L5 DRG were harvested (these DRG contain neurons that innervate the knee joint) and cells were cultured for 4 days; supernatants were collected for CX3CL1 ELISA.  For immunohistochemistry, mice were perfused transcardially with paraformaldehyde; L3-L5 DRG were dissected out or the spinal column was decalcified prior to spinal cord sectioning of the L3-L5 levels.  Anti-Iba1 or anti-cFos was used to examine microglia or neuronal activation, respectively, in the dorsal horn. 

Results:

In order to investigate whether changes in the DRG and DH of the spinal cord correlated with observed changes in locomotion, we focused on the 8-week post surgery time point.

Eight weeks post DMM, cultured DRG cells produced elevated levels of CX3CL1 protein compared to age-matched naïve DRG (p<0.05).  In addition, the DH in DMM mice showed markedly higher expression of Iba1 (marker of microglial activation) and of cFos (marker of neuronal activation) compared to age-matched naïve mice.

Conclusion:

This is the first report of increased fractalkine release by DRG neurons in a model of osteoarthritis, which may contribute to cellular activation in the DH.  Microglia and neuronal activation in the DH has been reported in murine mono-iodoacetate (MIA) arthritis (Ogbonna et al, 2013, Eur J Pain) and in non-disease-related animal models of nerve injury.  Longitudinal assessments of these dorsal horn changes are currently underway.  This will yield insight into how pain signaling spreads from the peripheral to the central nervous system in osteoarthritis.


Disclosure:

R. E. Miller,

Arthritis Foundation Post Doctoral Fellowship,

2;

P. Tran,
None;

R. J. Miller,

R01AR064251 (NIAMS) ,

2;

A. M. Malfait,

Allergan,

5.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pain-pathway-activation-in-dorsal-root-ganglia-and-dorsal-horn-in-a-murine-surgical-model-of-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology